A detailed history of Scholtz & Company, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Scholtz & Company, LLC holds 16,287 shares of PFE stock, worth $460,922. This represents 0.19% of its overall portfolio holdings.

Number of Shares
16,287
Previous 17,862 8.82%
Holding current value
$460,922
Previous $495,000 8.08%
% of portfolio
0.19%
Previous 0.22%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

SELL
$25.26 - $29.6 $39,784 - $46,620
-1,575 Reduced 8.82%
16,287 $455,000
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $93,204 - $107,028
-3,600 Reduced 16.77%
17,862 $495,000
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $560,802 - $728,420
21,462 New
21,462 $617,000
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $301,387 - $338,388
-8,150 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $344,062 - $378,010
-9,175 Reduced 52.96%
8,150 $346,000
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $154,841 - $176,536
4,025 Added 30.26%
17,325 $756,000
Q3 2017

Nov 14, 2017

BUY
$31.0 - $34.15 $412,300 - $454,195
13,300
13,300 $475,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $159B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Scholtz & Company, LLC Portfolio

Follow Scholtz & Company, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Scholtz & Company, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Scholtz & Company, LLC with notifications on news.